Navigation Links
Omeros Corporation Reports First Quarter 2011 Financial Results
Date:5/10/2011

tral nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, bleeding and central nervous system disorders.

Forward-looking StatementsThis press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, statements regarding Omeros' clinical plans for OMS103HP and OMS302 and that Omeros may have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 10, 2011. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future. OMEROS CORP
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... HILL, N.C. , March 27, 2015  The ... intimidating job description: ensure products meet quality standards at ... budgets and escalating regulations, quality leaders also have the ... and risk. Those who don,t effectively balance ... function as well as marketplace failure and regulatory scrutiny. ...
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
(Date:3/27/2015)... -- The Temple Health & Bioscience District (THBD) today announced ... 1802 South First St. in the Temple Medical and Education ... City of Temple to receive funding for redevelopment. ... Veterans Health Care System, the new facility will enable THBD ... and life science companies. Temple ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... 26 Healthy Advice ® Networks, the ... consumers and physicians, is pleased to announce they ... award-winning consumer health information once again by the ... such renowned institutions as the Mayo Clinic and ...
... Medco Health Solutions, Inc. (NYSE: MHS ) ... to help protect themselves against certain unnecessary health risks.  The ... of gaps in care that could harm their health and ... was announced today at Medco,s Best Practices Workshop, an annual ...
Cached Medicine Technology:Healthy Advice® Networks Wins 39 National Health Information Awards 2Healthy Advice® Networks Wins 39 National Health Information Awards 3Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 2Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 3Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks 4
(Date:3/29/2015)... Youth Villages will participate in a partnership with ... feasibility of implementing a Pay for Success model to ... families. , Third Sector Capital Partners Inc. ran a ... technical assistance throughout 2015 toward a Pay for Success ... chosen by Third Sector. The organization’s work with the ...
(Date:3/29/2015)... North American Seminars receives Texas Board ... Education Courses . , Utilizing Pilates to ... TPTA, approval # 56399TX      , The Interactive ... complex - 10.5 hours - Texas Board of Physical ... Treatment of the SI Joint - 10 hours - ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of ... of their new natural sunscreen. They are offering the ... Both options come with a bonus lip balm sunscreen. , ... Amazon. Click to see the natural sunscreen on ... sunscreen is made with non-nano zinc oxide and provides broad-based ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... 2015 Take a bite of warm, ... action. Acids tumble into the stomach, ready to break ... structure lets these acids run amok, triggering a burning ... symptom. More than 60 million Americans have heartburn at ... heartburn starts, and how it can be stopped. , ...
Breaking Medicine News(10 mins):Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2
... Jerusalem, Nov. 9, 2009 Research carried out among thousands ... a loss of bone mass, leading to osteoporosis and fractures. ... researchers, Prof. Raz Yirmiya, head of the Brain and Behavior ... They further revealed that the relationship between depression and bone ...
... SAN DIEGO, Nov. 9 Renewal Laboratories announced today ... produce functional beverages with important anti-oxidants and omega3 fatty ... Q10, resveratrol, and omega3 fish oil may now be ... company will soon premier a unique line of all ...
... Doctor house calls now ... ... pain management physician, will now offer routine house calls to residents of Manhattan in New York ... at 212-918-1629 or sending an email from davisbregman.com . The convenience of being able to ...
... ... both CAMTS and EURAMI accreditation and Department of Defense approval, , ... Birmingham, AL (PRWEB) November 9, 2009 ... full accreditation from the European Aero-Medical Institute (EURAMI). EURAMI is a Stuttgart, Germany, ...
... Bregman , a pain management physician will now offer routine house ... be able to request a house call by ... davisbregman.com . The convenience of being able to see the ... this new way of seeing most patients. The service will be ...
... O,Brien, president of Catholics for Choice, issued the following statement ... recent weeks tells us and the American voters a lot ... to our core values, seeking to overcome the struggles ordinary ... cannot afford basic healthcare or have to choose between maintaining ...
Cached Medicine News:Health News:Connection between depression and osteoporosis detailed by Hebrew University researchers 2Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Medicine Products: